{"id":2282,"date":"2023-07-04T08:09:00","date_gmt":"2023-07-04T08:09:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=2282"},"modified":"2023-07-05T08:09:37","modified_gmt":"2023-07-05T08:09:37","slug":"first-ai-generated-drug-given-go-ahead-for-human-trials","status":"publish","type":"post","link":"https:\/\/dailyai.com\/nb\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","title":{"rendered":"Det f\u00f8rste AI-genererte legemiddelet f\u00e5r klarsignal for utpr\u00f8ving p\u00e5 mennesker"},"content":{"rendered":"<p><strong>Insilico Medicine har f\u00e5tt godkjenning for utpr\u00f8ving p\u00e5 mennesker av sitt fullstendig AI-genererte legemiddel.<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Legemidlet er utviklet som en potensiell behandling for idiopatisk lungefibrose (IPF), som er en degenerativ sykdom som for\u00e5rsaker arrdannelse og fortykkelse av lungevevet. IPF rammer rundt 100 000 mennesker bare i USA. Det nye legemiddelet, kalt INS018_055, skal pr\u00f8ves ut i 12 uker i Kina, og det er planlagt utvidede studier i Kina og USA.<\/span><\/p>\n<p><a href=\"https:\/\/insilico.com\/\"><span style=\"font-weight: 400;\">Insilico<\/span><\/a><span style=\"font-weight: 400;\"> er et Hongkong-basert bioteknologiselskap som bruker kunstig intelligens til \u00e5 utvikle nye legemidler og til forskning p\u00e5 anti-aldring. Anvendelsen av kunstig intelligens i forskningen har gjort det mulig \u00e5 utvikle nye legemidler mye raskere.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\"Med kunstig intelligens kan vi analysere enorme datamengder og finne sammenhenger som menneskelige forskere kanskje overser, og deretter \"forestille oss\" helt nye molekyler som kan gj\u00f8res om til legemidler\", sier Alex Zhavoronkov, grunnlegger og administrerende direkt\u00f8r i Insilico Medicine.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Selskapet bruker kunstig intelligens i hvert trinn av sin strategi for legemiddelutvikling. F\u00f8rst bruker de sitt AI-drevne verkt\u00f8y, PandaOmics, til \u00e5 identifisere et \"target\" eller en biologisk \u00e5rsak knyttet til en spesifikk sykdom. M\u00e5let kan for eksempel v\u00e6re et gen eller protein som ikke fungerer som det skal.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">N\u00e5r de har identifisert et m\u00e5l, bruker de sin andre AI-plattform, Chemistry42, til \u00e5 designe et molekyl som vil rette opp problemet ved \u00e5 blokkere m\u00e5let uten \u00e5 skade pasienten.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">I dette tilfellet refererer \"55\" i legemiddelnavnet til det 55. molekylet som ble utviklet og viste lovende resultater.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Fase II-studiene som er godkjent, har som m\u00e5l \u00e5 se om medikamentet gir en signifikant respons hos de f\u00f8rste deltakerne. Hvis det lykkes, g\u00e5r man videre til fase III-studier for \u00e5 bekrefte sikkerhet og effektivitet f\u00f8r FDA-godkjenning kan gis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Insilico Medicine har en rekke interessante AI-legemiddelutviklinger p\u00e5 gang. FDA har nylig godkjent den f\u00f8rste IND-s\u00f8knaden (Investigational New Drug) for deres kreftlegemiddel rettet mot solide svulster. Fase I-studier er planlagt i juli 2023 i USA og Kina.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">N\u00e5r vi h\u00f8rer om generativ AI, tenker vi vanligvis p\u00e5 bilder, sanger eller tekst som genereres. Men Insilico bruker generativ AI til \u00e5 identifisere m\u00e5lmolekyler som for\u00e5rsaker en sykdom, og deretter utforme molekyler som retter seg direkte mot disse m\u00e5lmolekylene.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Hvis du sp\u00f8r ChatGPT om hvilke proteiner som kan brukes til \u00e5 behandle en bestemt type brystkreft, kan den identifisere dem fordi den har tilgang til publisert medisinsk forskning. Insilico har sin egen LLM kalt ChatPandaGPT, som gj\u00f8r det mulig for forskere \u00e5 bruke naturlige spr\u00e5ksp\u00f8rsm\u00e5l til \u00e5 sile gjennom en spesialisert kunnskapsbase med store mengder kliniske data.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Ved hjelp av <\/span><a href=\"https:\/\/dailyai.com\/nb\/2023\/06\/researchers-create-high-performance-ai-model-to-detect-heart-disease-from-ecgs\/\"><span style=\"font-weight: 400;\">Kunstig intelligens i medisin<\/span><\/a><span style=\"font-weight: 400;\"> hjelper selskaper som Insilico med \u00e5 forkorte prosessen med \u00e5 finne nye legemidler dramatisk. Deres <\/span><a href=\"https:\/\/insilico.com\/pipeline\"><span style=\"font-weight: 400;\">forskningspipeline<\/span><\/a><span style=\"font-weight: 400;\"> har en spennende rekke potensielle behandlinger for ulike typer kreft, i tillegg til et covid-19-medikament som ogs\u00e5 er i fase I-studier.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Insilico Medicine har f\u00e5tt godkjenning for utpr\u00f8ving p\u00e5 mennesker av sitt fullstendig AI-genererte legemiddel. Legemiddelet er utviklet som en potensiell behandling for idiopatisk lungefibrose (IPF), som er en degenerativ sykdom som for\u00e5rsaker arrdannelse og fortykkelse av lungevevet. IPF rammer rundt 100 000 mennesker bare i USA. Det nye legemiddelet, kalt INS018_055, skal pr\u00f8ves ut i 12 uker i Kina, og det er planlagt utvidede studier i Kina og USA. Insilico er et Hongkong-basert bioteknologiselskap som bruker kunstig intelligens til \u00e5 utvikle nye legemidler og til \u00e5 forske p\u00e5 aldring. Anvendelsen av kunstig intelligens i deres<\/p>","protected":false},"author":6,"featured_media":2283,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84],"tags":[150,107,101],"class_list":["post-2282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-ai-benefits","tag-generative-ai","tag-medtech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First AI-generated drug given go-ahead for human trials | DailyAI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/nb\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:locale\" content=\"nb_NO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First AI-generated drug given go-ahead for human trials | DailyAI\" \/>\n<meta property=\"og:description\" content=\"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/nb\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-04T08:09:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-05T08:09:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Eugene van der Watt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eugene van der Watt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ansl. lesetid\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"author\":{\"name\":\"Eugene van der Watt\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\"},\"headline\":\"First AI-generated drug given go-ahead for human trials\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"wordCount\":479,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"keywords\":[\"AI benefits\",\"Generative AI\",\"MedTech\"],\"articleSection\":[\"Industry\"],\"inLanguage\":\"nb-NO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"name\":\"First AI-generated drug given go-ahead for human trials | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\"},\"inLanguage\":\"nb-NO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"width\":1000,\"height\":563,\"caption\":\"AI generated drug gets human trial approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First AI-generated drug given go-ahead for human trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nb-NO\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\",\"name\":\"Eugene van der Watt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"caption\":\"Eugene van der Watt\"},\"description\":\"Eugene comes from an electronic engineering background and loves all things tech. When he takes a break from consuming AI news you'll find him at the snooker table.\",\"sameAs\":[\"www.linkedin.com\\\/in\\\/eugene-van-der-watt-16828119\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/nb\\\/author\\\/eugene\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Det f\u00f8rste AI-genererte legemiddelet f\u00e5r klarsignal for utpr\u00f8ving p\u00e5 mennesker | DailyAI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/nb\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_locale":"nb_NO","og_type":"article","og_title":"First AI-generated drug given go-ahead for human trials | DailyAI","og_description":"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their","og_url":"https:\/\/dailyai.com\/nb\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_site_name":"DailyAI","article_published_time":"2023-07-04T08:09:00+00:00","article_modified_time":"2023-07-05T08:09:37+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","type":"image\/jpeg"}],"author":"Eugene van der Watt","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Skrevet av":"Eugene van der Watt","Ansl. lesetid":"3 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"author":{"name":"Eugene van der Watt","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa"},"headline":"First AI-generated drug given go-ahead for human trials","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"wordCount":479,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","keywords":["AI benefits","Generative AI","MedTech"],"articleSection":["Industry"],"inLanguage":"nb-NO"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","url":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","name":"Det f\u00f8rste AI-genererte legemiddelet f\u00e5r klarsignal for utpr\u00f8ving p\u00e5 mennesker | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","breadcrumb":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb"},"inLanguage":"nb-NO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"]}]},{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","width":1000,"height":563,"caption":"AI generated drug gets human trial approval"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"First AI-generated drug given go-ahead for human trials"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DagligAI","description":"Din daglige dose med AI-nyheter","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nb-NO"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DagligAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa","name":"Eugene van der Watt","image":{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","caption":"Eugene van der Watt"},"description":"Eugene har bakgrunn som elektroingeni\u00f8r og elsker alt som har med teknologi \u00e5 gj\u00f8re. N\u00e5r han tar en pause fra AI-nyhetene, finner du ham ved snookerbordet.","sameAs":["www.linkedin.com\/in\/eugene-van-der-watt-16828119"],"url":"https:\/\/dailyai.com\/nb\/author\/eugene\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/posts\/2282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/comments?post=2282"}],"version-history":[{"count":1,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/posts\/2282\/revisions"}],"predecessor-version":[{"id":2284,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/posts\/2282\/revisions\/2284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/media\/2283"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/media?parent=2282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/categories?post=2282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/tags?post=2282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}